Search

Search Constraints

You searched for: Author/Creator Hammar, Niklas

Search Results

51. Quality of life in people with type 2 diabetes in the 3 years following initiation of second-line therapy: The DISCOVER study. (March 2022)

52. Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2‐inhibitors versus other glucose‐lowering agents in real‐world clinical practice: Results from the CVD‐REAL study. Issue 8 (17th April 2018)

54. Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)". Issue 9 (27th February 2018)

55. Serum inflammatory markers in relation to prostate cancer severity and death. (March 2018)

56. Serum inflammatory markers in relation to prostate cancer severity and death. Issue 11 (November 2017)

58. Socioeconomic factors associated with hypoglycaemia in patients starting second-line glucose-lowering therapy: The DISCOVER study. (July 2020)

59. The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohort. Issue 6 (21st June 2017)